{
    "clinical_study": {
        "@rank": "63716", 
        "arm_group": {
            "arm_group_label": "single arm study", 
            "arm_group_type": "Experimental", 
            "description": "treatment of degenerative disc disease using the PROW LIF"
        }, 
        "brief_summary": {
            "textblock": "This is a prospective, single-arm, open-label, non-randomized study. The aim of the study is\n      to assess the safety and efficacy of the Prow LIF procedure in Transforaminal Lumbar\n      Interbody Fusion (TLIF) procedures for the treatment of subjects with symptomatic\n      degenerative disc disease (DDD)."
        }, 
        "brief_title": "Prospective Study To Assess The Safety and Efficacy of the PROW LIF Procedure", 
        "completion_date": {
            "#text": "December 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Degenerative Disc Disease", 
        "condition_browse": {
            "mesh_term": "Intervertebral Disk Degeneration"
        }, 
        "detailed_description": {
            "textblock": "Primary endpoints:\n\n        -  Safety: Incidence of device-related anticipated and unanticipated serious adverse\n           events (SAE). However, ALL complications and adverse events (AE) will be monitored and\n           recorded.\n\n        -  Primary radiographic effectiveness outcome parameter: evaluations of fusion rate."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:main Inclusion Criteria\n\n          1. Male and female between 18-65 years of age (skeletally mature).\n\n          2. Subjects suffering from degenerative disc disease (DDD) accompanied by back pain with\n             leg pain at a single level between L2 and S1 confirmed by history and radiographic\n             studies and that are scheduled for a fusion operation. DDD is determined to be\n             present if one or more of the following are noted:\n\n               1. instability (defined as angulation \u2265 5\u00b0 and/or translation \u2265 4mm on\n                  flexion/extension radiographs);\n\n               2. osteophyte formation;\n\n               3. decreased disc height;\n\n               4. ligamentous thickening;\n\n               5. disc degeneration/herniation; or\n\n               6. facet joint degeneration.\n\n          3. A pre-op Oswestry Low Back Pain Disability Questionnaire (ODI) score of 35 % or more;\n\n          4. Be non-responsive to non-operative treatment for at least 6 months;\n\n             -\n\n        Exclusion Criteria:\n\n          1. The Antero-Posterior (AP) diameter (at midline) of the involved level is <31mm.\n\n          2. Any previous spinal surgery at the involved level;\n\n          3. Spondylolisthesis > grade I;\n\n          4. Ankylosed segment at the affected level;\n\n          5. History or radiographic evidence of  osteoporotic fractures in the spine;\n\n          6. Paraparesis;\n\n          7. Progressive neurologic conditions;\n\n             -"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "15", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 30, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01850537", 
            "org_study_id": "CLN0171"
        }, 
        "intervention": {
            "arm_group_label": "single arm study", 
            "description": "TLIF procedure for the treatment of degenerative disc disease using the PROW LIF procedure (system)", 
            "intervention_name": "treatment of degenerative disc disease using the PROW LIF", 
            "intervention_type": "Device", 
            "other_name": "PROW LIF Procedure"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "DDD", 
            "PROW", 
            "FUSION", 
            "eSPIN", 
            "Cage", 
            "IBF", 
            "Discectomy", 
            "Lumbar Fusion", 
            "TLIF", 
            "MIS"
        ], 
        "lastchanged_date": "May 6, 2013", 
        "link": {
            "description": "NLT SPINE website", 
            "url": "http://www.nlt-spine.com"
        }, 
        "location": {
            "contact": {
                "email": "leitner@clalit.org.il", 
                "last_name": "Joseph Leitner, MD Dr.", 
                "phone": "+972- 97472590"
            }, 
            "facility": {
                "address": {
                    "city": "Kfar Saba", 
                    "country": "Israel"
                }, 
                "name": "Spine Surgery Department, Meir Hospital, Israel"
            }, 
            "investigator": {
                "last_name": "Joseph Leitner, MD Dr.", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_arms": "1", 
        "official_title": "Prospective Study To Assess The Safety and Efficacy of the PROW LIF Procedure", 
        "overall_contact": {
            "email": "leitner@clalit.org.il", 
            "last_name": "Josef Leitner, MD DR.", 
            "phone": "+972-9-7472590"
        }, 
        "overall_contact_backup": {
            "email": "orly.s@nlt-spine.com", 
            "last_name": "Orly Schwartz, B.Sc", 
            "phone": "+972-3-6344514", 
            "phone_ext": "218"
        }, 
        "overall_official": {
            "affiliation": "Head of the Spine surgery department, Meir Hospital", 
            "last_name": "Joseph Leitner, MD Dr.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Israel: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Primary radiographic effectiveness outcome parameter: evaluations of fusion. Fusion will be evaluated at 6 months, 12 months and 24 months post-op using plain radiographs (AP, lateral and flexion/extension films) and at 24 months using CT scan as well", 
            "measure": "Fusion rate", 
            "safety_issue": "No", 
            "time_frame": "24 months follow up"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01850537"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "NLT Spine", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "NLT Spine", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}